Sammanfattning
Upcoming clinical trials assessing transplantation of stem cell-derived dopaminergic neurons into the striatum in patients with Parkinson's disease could generate groundbreaking results on neuronal replacement in the human brain. However, as highlighted here, the road toward a clinically competitive treatment for this multisystem disorder will probably be long and winding.
Originalspråk | engelska |
---|---|
Sidor (från-till) | 519-522 |
Antal sidor | 4 |
Tidskrift | Cell Stem Cell |
Volym | 27 |
Nummer | 4 |
DOI | |
Status | Published - 2020 |
Ämnesklassifikation (UKÄ)
- Neurovetenskaper